WASHINGTON (Reuters) - Senior managers from some of the world's largest over-the-counter (OTC) derivatives firms, currently accustomed to little government scrutiny, are scheduled to testify on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback